{
    "2020-12-29": [
        [
            {
                "time": "",
                "original_text": "医疗健康：疫苗突破美国大选进展 行业调整与继续分化",
                "features": {
                    "keywords": [
                        "疫苗",
                        "美国大选",
                        "行业调整",
                        "分化"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗健康"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药行业2020年医保谈判事件点评：医保谈判结果公布 继续看好创新药和产业链",
                "features": {
                    "keywords": [
                        "医保谈判",
                        "创新药",
                        "产业链"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药行业周报：海外疫情引关注 “国谈”下创新药企业面临新考验",
                "features": {
                    "keywords": [
                        "海外疫情",
                        "国谈",
                        "创新药",
                        "考验"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "中泰国际：医药行业给予推荐评级 重点推荐药明康德",
                "features": {
                    "keywords": [
                        "中泰国际",
                        "推荐评级",
                        "药明康德"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业报告：继续重点关注创新核心竞争力和医药大消费两大投资方向",
                "features": {
                    "keywords": [
                        "创新核心竞争力",
                        "医药大消费",
                        "投资方向"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "高瓴易诺青：连投8轮百济神州，坚定重仓大健康、大医疗，有两条投资原则",
                "features": {
                    "keywords": [
                        "高瓴",
                        "百济神州",
                        "大健康",
                        "大医疗",
                        "投资原则"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "大健康",
                        "大医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-12-28",
                "original_text": "【山证医药】医药行业周报（20201228）：新冠疫苗上市临近，持续关注后续动态",
                "features": {
                    "keywords": [
                        "新冠疫苗",
                        "上市",
                        "后续动态"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "锚定“长坡厚雪”，A股渐趋赛道化",
                "features": {
                    "keywords": [
                        "长坡厚雪",
                        "A股",
                        "赛道化"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "A股"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "药明康德：市值业绩双高 加码CXO",
                "features": {
                    "keywords": [
                        "药明康德",
                        "市值",
                        "业绩",
                        "CXO"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}